Kodiak Sciences Inc KOD Debt-to-equity

Debt-to-equity at other companies

Regeneron PharmaceuticalsREGN

0.1×0.0×

EyePoint, Inc.EYPT

0.1×0.0×

KLR

Kalaris TherapeuticsKLRS

0×—

4D Molecular TherapeuticsFDMT

0×0.0×

HRO

HarrowHROW

10.7×+2.6×

PVL

Palvella TherapeuticsPVLA

0×—

FAQ

What is Kodiak Sciences Inc's debt-to-equity?

Kodiak Sciences Inc (KOD) reported debt-to-equity of 0.5× in Q1 2026.

How has Kodiak Sciences Inc's debt-to-equity changed year-over-year?

Kodiak Sciences Inc's debt-to-equity decreased by 19.6% year-over-year, from 0.6× to 0.5×.

What is the long-term trend for Kodiak Sciences Inc's debt-to-equity?

Over 5 years (2020 to 2025), Kodiak Sciences Inc's debt-to-equity has grown at a 33.1% compound annual growth rate (CAGR), from 0.1× to 0.4×.

What does debt-to-equity mean?

Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.